UK Government Report Reveals That British Children, 10 to 14 Years Old, Up to 52 Times More Likely To Die After Getting a C0VID Shot
By Steve Kirsch
New data from the ONS in the UK shows a 52X increase in all-cause mortality if you got two jabs compared to the unvaccinated. Might explain why informed kids aren’t rushing to get jabbed.
The key part are the stats on all-cause mortality which I’ve always said is the elephant in the room:
10–14-year-olds, on the other hand, run the risk of dying almost by a factor of ten following the first dose while the second dose brings a 51.8 times greater risk of death than if they had remained un-jabbed.
I’ve applied to speak at the upcoming FDA and CDC meetings and would like to use this in my oral testimony.
If you can find an error in the analysis or can explain why the all cause mortality is dose dependent, let me know in the comments below.
Comment from Robert
@Steve Kirsch: To answer your questions, I downloaded the spreadsheet database from ONS and ran the numbers myself (simple enough). I replicated the results reported by LifeSiteNews, so their calculations are correct (assuming the ONS data are correct–see Dr. Fenton’s group on that). You can view the calculations and download the spreadsheet from my Microsoft OneDrive public folder here: https://1drv.ms/u/s!AndbPKOlZp6xgrl7eePhR9DESmu1Dw?e=nIs5LL. Look at the Table 9 tab.
However, I have a few concerns:
(1) As others have mentioned, some of the numbers are based on very small subsets. For example, the extreme case of double-jabbed 10-14 y/o’s having 52x risk is founded on the following data: 1678 person-years (PY) with 4 non-COVID deaths, resulting in a rate of 238.4 non-COVID deaths per 100,000 PY. Compare that to the unvaccinated 10-14 y/o’s, where 1,094,711 PY and 94 non-COVID deaths resulted in a rate of 4.6. The ratio is where the 52x comes from. But I submit that the statistical uncertainty around 238.4 is much higher than around 4.6, due to the huge difference in PYs.
(2) Note that there were no non-COVID deaths in either age group in the group that was double-vaxxed <21 days ago. If deaths are vax-related, VAERS data would suggest a concentration in the first few days after vaccination, not an absence in the first 21 days and then a concentration afterwards. This raises questions as to how many of the >21 day deaths are truly vax-related.
(3) Keep in mind that the UK vaccinated the most vulnerable first. I don’t know how these doses were distributed in Beta vs. Delta waves, but that could affect COVID death rates. However, in all these groups, COVID deaths were extremely low, except for the 15-19 y/o’s. It is puzzling that so many more of them died than the unvaxxed 10-14 y/o’s. That again makes me wonder about sample sizes and reliability.
(4) Overall, it would be ideal if more recent data were available since the vaccination of this age group only began recently in the general population, and that would enable larger PYs and thus statistical reliability.
I do think the trends merit further investigation, for sure. I just wouldn’t hang my hat on them just yet.
As to your second question, someone above provided a link to a video by Dr. Bhakdi:
Dr. Bhakdi discusses Burkhardt’s work in this video:
He says the t-lymphocytes attack the organs because the organs are expressing the spike proteins, and that is what the t-lymphocytes were trained to attack. Bhakdi says that it gets worse with increasing number of vaccinations, though 4 of the people had only had 1 injection. He says the blood vessels become leaky due to the first vaccine, and then with the second vaccination the mRNA leaks through the leaky blood vessels into the organs.
Additionally, the following may be of interest:
1. https://www.medrxiv.org/content/10.1101/2021.12.23.21268276v1 — showing the increased myocarditis risk with 2nd vs. 1st jab of Pfizer or Moderna. Earlier paper: https://www.nature.com/articles/s41591-021-01630-0?fr=operanews. They reported “there was an increase in the risk of myocarditis within a week of receiving the first dose of both adenovirus and mRNA vaccines, and a higher increased risk after the second dose of both mRNA vaccines.” They suggested that “vaccine mediated expression of SARS-CoV-2 surface spike protein on the surface of cardiomyocytes could potentially trigger an immunologic response resulting in organ-specific cell death[19,20].” If that is the mechanism, one can easily envision that the immunologic response might be stronger upon introduction of spike proteins from the second jab. One could imagine such immunologic responses not being limited to cardiomyocytes, but could contribute to increased mortality after the second jab from other damaged systems. Note that myocarditis could be subclinical and undetected, but then cause death of young athletes well past 21 days; such deaths could contribute to the anomaly noted above, where deaths are 0 at <21 days but elevated >21 days. Unfortunately, the database doesn’t provide descriptions of individual causes of death. (Further speculation on autoantibody generation, and an argument against a more generalized immunological reaction vs. one limited to the heart, is given here: https://www.nature.com/articles/s41569-021-00662-w?s=09).
2. Dr. Campbell reviews an Israeli study showing 56 of 62 cases of post-vax myocarditis came after the second shot.
The reason wasn’t given.
3. JAMA published this study showing increased rate of myocarditis after 2nd jab. https://jamanetwork.com/journals/jama/fullarticle/2788346. I list these just in case you need references to the higher incidence of myocarditis post-2nd-jab.
4. In Spring 2021, the German government recommended people under 60 not receive the second dose of Astra-Zeneca due to risk of blood clots (https://www.msn.com/en-us/news/us/german-vaccine-commission-says-people-under-60-shouldnt-receive-astrazeneca-second-dose/ar-BB1fdyFb?li=BBnb7Kz). Since Astra-Zeneca was heavily used in the UK, that could be another reason for the deaths in doubly vaxxed young people in the ONS database. (Again, doesn’t explain, but German government support for higher risk after 2nd jab).
5. This paper says, “the mRNA BNT162b2 vaccine induces complex functional reprogramming of innate immune responses, which should be considered in the development and use of this new class of vaccines.” https://www.medrxiv.org/content/10.1101/2021.05.03.21256520v1. Furthermore, “With this in mind, we also assessed the production of IFN-α by immune cells of the volunteers after vaccination. Although the concentrations of IFN-α were below the detection limit of the assay for most of the stimuli, we observed a significant reduction in the production if IFN-α secreted after stimulation with poly I:C and R848 after the administration of the second dose of the vaccine (Figure 1H, 1I). This may hamper the initial innate immune response against the virus, as defects in TLR7 have been shown to result in and increased susceptibility to COVID-19 in young males (Van Der Made et al., 2020). These results collectively demonstrate that the effects of the BNT162b2 vaccine go beyond the adaptive immune system and can also modulate innate immune responses.” To the extent post-vax deaths are related to infections/cancers/etc., perhaps this enhanced suppression of the innate immune system after 2 doses plays a role.